Yasushi Goto Selected Research

Yasushi Goto Research Topics

Disease

78	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 04/2008
52	Neoplasms (Cancer) 04/2024 - 11/2010
22	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2012
12	Disease Progression 04/2024 - 10/2012
11	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2008
9	Brain Neoplasms (Brain Tumor) 03/2024 - 05/2020
7	Thymoma (Thymic Carcinoma) 04/2024 - 01/2016
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 01/2017
4	Diarrhea 12/2022 - 10/2012
4	Carcinoma (Carcinomatosis) 01/2022 - 12/2008
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020 - 09/2010
3	Body Weight (Weight, Body) 03/2024 - 08/2016
3	Hypertriglyceridemia 05/2023 - 01/2013
3	Neutropenia 10/2020 - 04/2012
3	Adenocarcinoma of Lung 01/2018 - 02/2016
2	Hyperlipidemias (Hyperlipidemia) 03/2024 - 11/2020
2	Pneumonia (Pneumonitis) 10/2023 - 10/2022
2	Hypercholesterolemia 05/2023 - 04/2023
2	Edema (Dropsy) 05/2023 - 11/2020
2	Cachexia 01/2023 - 02/2022
2	Nausea 12/2022 - 03/2012
2	Thymus Neoplasms (Thymus Neoplasm) 12/2022 - 06/2012
2	Vomiting 12/2022 - 12/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2022 - 11/2020
2	Fatigue 12/2022 - 10/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Exanthema (Rash) 10/2020 - 01/2017
2	Chest Pain (Chest Pains) 01/2018 - 05/2013
2	Hypertension (High Blood Pressure) 10/2012 - 06/2012
2	Breast Neoplasms (Breast Cancer) 06/2012 - 08/2008
1	Dysbiosis 04/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023
1	Thrombosis (Thrombus) 10/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022

Drug/Important Bio-Agent (IBA)

20	Tyrosine Kinase InhibitorsIBA 04/2024 - 02/2016
16	ErbB Receptors (EGF Receptor)IBA 03/2024 - 10/2012
14	Immune Checkpoint InhibitorsIBA 03/2024 - 03/2016
13	lorlatinibIBA 03/2024 - 10/2020
12	NivolumabIBA 07/2023 - 10/2018
11	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
11	pembrolizumabIBA 04/2024 - 12/2020
11	CrizotinibIBA 03/2024 - 08/2016
11	B7-H1 AntigenIBA 01/2024 - 01/2017
9	PlatinumIBA 03/2024 - 11/2010
9	Anaplastic Lymphoma KinaseIBA 03/2024 - 01/2017
7	LigandsIBA 12/2023 - 01/2016
6	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2017
6	alectinibIBA 06/2023 - 01/2017
5	Docetaxel (Taxotere)FDA Link 03/2024 - 04/2008
5	osimertinibIBA 03/2024 - 07/2017
4	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 08/2012
4	Gefitinib (Iressa)FDA Link 04/2019 - 09/2010
3	AntibodiesIBA 04/2024 - 01/2021
3	trastuzumab deruxtecanIBA 04/2024 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 08/2012
3	Programmed Cell Death 1 ReceptorIBA 01/2023 - 10/2018
3	Cell-Free Nucleic AcidsIBA 11/2022 - 02/2016
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2020 - 07/2015
3	amrubicinIBA 11/2019 - 04/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 05/2013
2	Phosphotransferases (Kinase)IBA 04/2024 - 10/2021
2	atezolizumabIBA 03/2024 - 11/2023
2	canakinumab FDA Link 01/2024 - 10/2023
2	AntigensIBA 12/2023 - 01/2016
2	durvalumabIBA 10/2023 - 01/2022
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2017
2	RamucirumabIBA 01/2023 - 01/2019
2	Hormones (Hormone)IBA 02/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022 - 01/2016
2	Alanine Transaminase (SGPT)IBA 10/2020 - 07/2019
2	amrubicinolIBA 11/2019 - 04/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2016
1	lenvatinibIBA 04/2024
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	cabozantinibIBA 03/2024
1	Therapeutic UsesIBA 03/2024
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2024
1	patritumab deruxtecanIBA 12/2023
1	N 30IBA 12/2023
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2023
1	NucleotidesIBA 11/2023
1	InterleukinsIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	NF-kappa B (NF-kB)IBA 10/2023
1	Pemetrexed (MTA)FDA Link 08/2023
1	Formaldehyde (Formol)FDA Link 08/2023
1	ParaffinIBA 08/2023
1	cyclo(Arg-Pro) (CI 4)IBA 05/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	Chromogranin AIBA 12/2022
1	trans-sodium crocetinate (crocetin)IBA 12/2022

Therapy/Procedure

39	Therapeutics 03/2024 - 04/2008
31	Drug Therapy (Chemotherapy) 03/2024 - 04/2008
6	Chemoradiotherapy 10/2023 - 05/2013
4	Immunotherapy 04/2024 - 10/2022
3	Radiotherapy 11/2020 - 11/2017
2	Molecular Targeted Therapy 01/2018 - 12/2015
1	Surgical Instruments (Clip) 06/2023
1	Precision Medicine 06/2023
1	Retreatment 01/2023